Jonathan Dickinson

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan Dickinson

Jonathan Dickinson is recorded as CEO at Innate Pharma SA (IPHA). Jonathan Dickinson has spoken on 5 earnings calls and 2 other investor events across 1 company, most recently for Innate Pharma SA on September 14, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Innate Pharma SA (IPHA)
CEO

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Innate Pharma SA

IPHA

Current role

CEO

7 appearances Latest appearance 2026-09-14

View calls and events

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Conference H.C. Wainwright 28th Annual Global Investment Conference Innate Pharma SA (IPHA)
2026-09-14
Earnings call Earnings conference call (announced in 6-K) Innate Pharma SA (IPHA)
2026-05-13
Earnings call Innate Pharma SA Q1 FY2026 Earnings Call Innate Pharma SA (IPHA)
2026-03-26
Earnings call Innate Pharma SA Q3 FY2025 Earnings Call Innate Pharma SA (IPHA)
2025-09-30
Annual General Meeting Individual shareholders meeting Innate Pharma SA (IPHA)
2025-09-25
Earnings call Innate Pharma SA Q2 FY2025 Earnings Call Innate Pharma SA (IPHA)
2025-06-26
Earnings call Innate Pharma SA Q1 FY2025 Earnings Call Innate Pharma SA (IPHA)
2025-03-31